| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
HGFAngiogenesisNK4Dendritic cell (Immunology)G CSFRegulatory T cellTGF betaTolerance (Immunology)Vasoactive intestinal peptideInterleukin10METFibrosisSMAD3SMAD2SnoNTGIF| 1 | 1996 | The HGF receptor family: unconventional signal transducers for invasive cell growth. | 
| + | - | nl | Genes Cells 1(4):347-54 (1996) |
| 2 | 2008 | The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. | 
| + | - | nl | BMB Rep 41(12):833-9 (2008) |
| 3 | 2003 | NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. | 
| + | - | nl | Cancer Sci 94(4):321-7 (2003) |
| 4 | 1995 | The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. | 
| + | - | nl | J Cell Biol 129(5):1177-80 (1995) |
| 5 | 2006 | Tolerogenic dendritic cells: cytokine modulation comes of age. | 
| + | - | nl | Blood 108(5):1435-40 (2006) |
| 6 | 2010 | MET molecular mechanisms and therapies in lung cancer. | 
| + | - | nl | Cell Adh Migr 4(1):146-52 (2010) |
| 7 | 2010 | The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. | 
| + | - | nl | Proc Jpn Acad Ser B Phys Biol Sci 86(6):588-610 (2010) |
| 8 | 2004 | Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. | 
| + | - | nl | Am J Physiol Renal Physiol 287(1):F7-16 (2004) |